IL6 and myocardial infarction: Using a rat model of reperfused MI, we demonstrated that sgp130Fc, but not anti–IL-6-Ab, attenuated neutrophil and macrophage infiltration into the myocardium, reduced infarct size, and preserved cardiac function 28 days after MI.